Healthcare Services Market to Grow by USD 6.26 Trillion from 2024 to 2028, Driven by Rising Chronic Disease Prevalence, Report on AI's Impact
Healthcare Services Market 2024-2028: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The healthcare services market report covers the following areas:
Healthcare Services Market Size
Healthcare Services Market Trends
Healthcare Services Market Industry Analysis
Porter's Five Forces Analysis
Customer Landscape
The healthcare services market is fragmented, and the degree of fragmentation will accelerate. The increasing prevalence of chronic diseases will offer immense growth opportunities. However, the Increasing healthcare costs will hamper the market growth
Healthcare Services Market 2024-2028: Drivers & Challenges
Chronic diseases, including cardiovascular diseases (CVDs), cancer, chronic obstructive pulmonary disease (COPD), and type-2 diabetes, are major health concerns worldwide, accounting for 74% of all global deaths according to the World Health Organization (WHO). These diseases are often caused by modifiable risk factors such as high blood pressure, high blood cholesterol, obesity, unhealthy diets, and tobacco use. For instance, CVDs are the leading cause of non-communicable disease (NCD) deaths, claiming 17.9 million lives annually. It is essential for healthcare services to focus on prevention and early detection to reduce the burden of these diseases. Healthcare providers can offer education on healthy lifestyle choices, regular screenings, and effective treatment options to help manage and prevent chronic diseases.
The global healthcare services market faces substantial challenges due to escalating healthcare costs. This trend negatively affects various aspects, including access to care and service quality. For instance, US healthcare spending grew 4.1% in 2022, reaching approximately USD4.5 trillion or USD13,493 per person (Centers for Medicare and Medicaid Services). This increase in costs makes it harder for individuals and families to afford essential medical treatments and services. Consequently, access to care becomes limited, potentially impacting overall healthcare system sustainability.
To learn more about the global trends impacting the future of market research, download a PDF sample
Segment Overview
This healthcare services market report extensively covers market segmentation by
End-user
Service
Geography
1.1 Adult care- The adult care segment in the healthcare services market caters to the unique healthcare needs of adults, ranging from young adults to older individuals. This segment includes preventive screenings, chronic disease management, acute care for illnesses and injuries, behavioral health services, and women's health services. Adult care providers collaborate to deliver comprehensive care, including primary care physicians, specialists, nurses, therapists, and allied health professionals. The adult care segment addresses the growing healthcare needs of the global population, including the rising prevalence of chronic conditions, mental health disorders, lifestyle-related illnesses, and age-related health concerns. Providers focus on preventive care, early detection, and personalized treatment plans to optimize health outcomes and improve quality of life. Advancements in medical research, technology, and treatment modalities have enhanced adult care services, enabling tailored treatments, precision medicine, and minimally invasive procedures. Digital health solutions, telemedicine, and electronic health records facilitate improved care coordination, patient engagement, and access to services. The adult care segment is evolving to meet changing healthcare needs, emphasizing holistic care approaches, patient-centered care models, and shared decision-making. Healthcare organizations promote health and wellness initiatives, lifestyle modifications, and patient education to empower adults to manage their health and preventive care. These factors are expected to drive the growth of the adult care segment in the global healthcare services market.
To learn more, request a FREE sample
Healthcare Services Market 2024-2028: Key Highlights
CAGR of the market during the forecast period 2024-2028
Detailed information on factors that will assist healthcare services market growth during the next five years
Estimation of the healthcare services market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the healthcare services market across North America, Europe, Asia, and Rest of World (ROW)
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of healthcare services market vendors
Healthcare Services Market Scope
Report Coverage
Details
Base year
2023
Historic period
2017-2021
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 8.73%
Market growth 2024-2028
USD 6263.7 billion
Market structure
Fragmented
YoY growth 2022-2023 (%)
7.43
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 35%
Key countries
US, Germany, and China
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
Apollo Hospitals Enterprise Ltd, athenahealth Inc., Community Health Systems Inc., CVS Health Corp., DaVita Inc., Dr Lal PathLabs Ltd., Expedient Healthcare Marketing Pvt. Ltd., Fresenius Medical Care AG and Co. KGaA, Genesis Healthcare Inc., iHealth Labs Inc., Max Healthcare Institute Ltd, Mayo Foundation for Medical Education and Research, McKesson Corp., OMH HealthEdge Holdings LLC, Optum Inc., Quest Diagnostics Inc., Sonic Healthcare Ltd., Universal Health Services Inc., and West Suffolk NHS Foundation Trust
Market dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
About USTechnavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.comWebsite: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/healthcare-services-market-to-grow-by-usd-6-26-trillion-from-2024-to-2028--driven-by-rising-chronic-disease-prevalence-report-on-ais-impact--technavio-302377048.html
SOURCE Technavio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott
The U.S. acute external ventricular drain market, valued at USD 86.5 million in 2024, is set to grow at a CAGR of 7.9% from 2025 to 2030. Growth is driven by increased demand for noninvasive neurosurgeries, technological innovations, and rising healthcare spending. Favorable reimbursement policies and an aging population further fuel market expansion. U.S. Acute External Ventricular Drain Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Acute External Ventricular Drain Market Size, Share & Trends Analysis Report By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage), By Patient Type (Pediatric, Adult), And Segment Forecasts, 2025 - 2030" report has been added to U.S. acute external ventricular drain market size was valued at USD 86.5 million in 2024 and is projected to grow at a CAGR of 7.9% from 2025 to 2030 The growth is expected to be driven by the rising prevalence of non-traumatic hydrocephalus, increased demand for minimal or noninvasive neurosurgeries, and the rising adoption of technologically improved devices. With the growing incidence of accidents, sports injuries, and strokes, the demand for external ventricular drain (EVD) procedures is rising steadily. As the aging population expands, the prevalence of conditions like strokes and aneurysms rises, further boosting the need for EVD procedures. For instance, according to the World Bank Group, the total population aged 65 and above in the U.S. was 49.98 million in 2018, increasing to 58.38 million in 2023. In addition, advancements in healthcare infrastructure and the rising number of emergency and trauma centers equipped to handle acute neurological cases contribute to market innovations in EVD systems, such as improved catheter designs, antimicrobial coatings, and integrated monitoring capabilities, enhance patient outcomes and reduce infection risks, making these devices more appealing to healthcare providers. Hospitals and clinics increasingly adopt these advanced EVD systems to improve treatment efficiency and minimize complications. Moreover, the growing emphasis on minimally invasive neurosurgical techniques supports the demand for EVDs, as they offer a less invasive solution for managing CSF drainage than traditional surgical factor fueling market expansion is the rising healthcare expenditure in the U.S., coupled with favorable reimbursement policies for neurological procedures. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased by 7.5% in 2023, reaching USD 4.9 trillion, which amounts to USD 14,570 per person. Insurance coverage for EVD placements and related treatments ensures broader patient access, encouraging hospitals to invest in these devices. Furthermore, increased physician awareness about the benefits of early and effective CSF management in critical care settings drives higher adoption rates.U.S. Acute External Ventricular Drain Market Report SegmentationApplication Outlook (Revenue, USD Million, 2018 - 2030) Traumatic Brain Injury Subarachnoid hemorrhage Intracerebral hemorrhage Other Non-Traumatic Hydrocephalus conditions Patient Type Outlook (Revenue, USD Million, 2018 - 2030) Pediatric Adult Why should you buy this report? Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments. Competitive Landscape: Explore the market presence of key players worldwide. Future Trends: Discover the pivotal trends and drivers shaping the future of the global market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $86.5 Million Forecasted Market Value (USD) by 2030 $135.8 Million Compound Annual Growth Rate 7.9% Regions Covered United States U.S. Acute External Ventricular Drain Market Variables, Trends & Scope Market Lineage Outlook Parent market outlook Related/ancillary market outlook Market Dynamics Market driver analysis Market restraint analysis U.S. Acute External Ventricular Drain Market Analysis Tools Industry Analysis - Porter's PESTEL Analysis U.S. Acute External Ventricular Drain Market: Pipeline Analysis Companies Featured Medtronic Integra LifeSciences Corporation Anuncia Medical, Inc. Natus Fuji Systems B Braun/Aesculap Boston Scientific Abbott For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Acute External Ventricular Drain Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Mergers and Acquisitions Fuel Growth, Telehealth Adoption Boosts Software Usage
The US Long Term Care Market is projected to reach USD 729.78 billion by 2030, growing at a CAGR of 7.71% from 2025. Key growth drivers include the rising prevalence of chronic diseases, an increasing geriatric population, and technological advancements. Nursing care centers lead the market. U.S. Long Term Care Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Long Term Care Market Size, Share & Trends Analysis Report By Service (Home Health Care, Hospices, Nursing care, Assisted living facilities), By Payer (Public, Private), And Segment Forecasts, 2025 - 2030" has been added to offering. The U.S. long-term care market is poised for significant growth, anticipated to reach USD 729.78 billion by 2030 with a CAGR of 7.71% from 2025 to 2030 Key drivers include the high incidence of chronic diseases such as Alzheimer's, heart diseases, and diabetes, as reported by the CDC, which notes that 60% of adults are affected by chronic conditions. The aging population, escalating healthcare costs, and the prevalence of nuclear families are further propelling the market growth. Additionally, advancements in technology and the accessibility of Medicare, Medicaid, and private insurance contribute substantially to the market expansion. The U.S. government supports long-term care initiatives through regulations like the New York State Public Health Law Article 21-A, mandating pneumococcal and influenza vaccinations for residents and healthcare professionals in facilities. Consequently, demand for immunization resources in long-term care facilities is surging. The healthcare system's focus on treating COVID-19 has led to the neglect of chronic conditions, increasing demand for long-term care services such as skilled nursing, home healthcare, and assisted living facilities. These services alleviate the burden on hospitals by providing essential care and post-surgery recovery. In 2021, data from the American Hospital Association indicated over 36 million hospitalizations in the U.S., underscoring the need for long-term care solutions. U.S. Long Term Care Market Report Highlights Nursing care facilities held a revenue share of 35.48% in 2024, attributed to their widespread presence and comprehensive medical services. The demand for long-term care is expanding beyond the elderly to include varied age groups, presenting opportunities for home healthcare providers. Strategic mergers and partnerships are reshaping the market landscape. In October 2021, Amedisys expanded its home healthcare services in North Carolina, and in May 2025, Sunrise Senior Living partnered with Griffin Living to enhance senior living options in California. Group purchasing organizations like GeriMed are critical to the sector, ensuring efficient distribution of medical supplies and pharmaceuticals to long-term care facilities. The adoption of telehealth solutions since 2020 is boosting the uptake of long-term care software, with home healthcare centers and skilled nursing facilities leading adoption rates. Why should you buy this report? Gain comprehensive insights into the global market, segmented by region. Explore the competitive landscape and market standing of key players globally. Identify future trends and drivers shaping the market's trajectory. Leverage actionable recommendations to uncover new revenue avenues and inform strategic decisions. Key Attributes: Report Attribute Details No. of Pages 100 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $470.66 Billion Forecasted Market Value (USD) by 2030 $729.78 Billion Compound Annual Growth Rate 7.7% Regions Covered United States Companies Featured Brookdale Senior Living, Inc Sunrise Senior Living, LLC Kindred Healthcare Amedisys, Inc Genesis Healthcare, Inc Capital Senior Living Corporation Diversicare Healthcare Services, Inc Home Instead, Inc. Senior Care Centerz Atria's Senior Living For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Long Term Care Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
North America Leads in MRD Testing Market with Advanced Reimbursement Ecosystem
The Minimal Residue Disease (MRD) Testing Market is projected to reach USD 4.50 billion by 2030, with a CAGR of 10.1% from 2025. Key drivers include the rising use of MRD tests in cancer prognosis and personalized medicine. In 2024, flow cytometry and hematological malignancies held major market shares. North America leads due to advanced diagnostics and healthcare infrastructure. This report offers comprehensive insights and strategic recommendations. Minimal Residual Disease Testing Market Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market Size, Share & Trends Analysis Report By Technology (NGS, PCR), By Cancer Type (Hematological Malignancy, Solid Tumors), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030" report has been added to global minimal residual disease testing market size is estimated to reach USD 4.50 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030. The adoption of MRD testing as a novel diagnostic and prognostic assay facilitates robust moderation of treatment regimes to treat all kinds of hematological malignancies. Measurement of therapeutic outcomes is critical for the successful adoption of a given cancer therapeutic regime. MRD generates important molecular information to better understand the cancer conditions and ultimately work towards leveraging treatment outcomes. Therefore, MRD testing is increasingly used as an end-point analysis step in numerous clinical trial studies for oncology-based research and also effectively records the variations in outcomes due to individual genetic characteristics. For instance, in November 2020, Adaptive Biotechnologies Corporation, entered into a collaboration with GlaxoSmithKline plc., to use its clonoSEQ assay for the assessment of residual cancer cells after treatment with GSK's hematology removal of tumors with other associative therapies does not essentially mean, that the cancerous cells are removed completely. Traces of cancer can remain in the body parts and bloodstream. The diagnosis of such residual cells is crucial for deciding upon the need for further rounds of chemotherapy and radiation. Researchers are devising non-invasive tests to effectively detect MRD. For instance, in February 2022, a blood test from C2i Genomics quantified the residual cancer cells after surgical oncology procedures. The C2inform test also achieved the CE mark clearance and is offered as a 'software-as-a-medical-device' MRD test in therapeutics are effectively moderated to avoid a residue of tumorous cells using the relevant clinical evidence and are also personalized based on specific progression profiles in an individual. Numerous research studies are driving the need for consideration of individual genetic characteristics for effective Residue Disease Testing Market Report Highlights By technology, the flow cytometry segment held a dominant share in the minimal residual disease testing market in 2024, owing to the high sensitivity and wide applicability of MRD testing. By cancer type, the hematological malignancy cancer dominated the market with a revenue share of 68.58% in 2024, owing to the increasing prevalence of hematological malignancy. By end-use, the hospitals and specialty clinics segment is the highest revenue-generating segment in 2024, owing to the availability of advanced diagnostic devices and skilled professionals in hospitals and specialty clinics. North America dominated the minimal residual disease testing market in 2024, which is attributed to the growing prevalence of hematological malignancies in the region aided by a well-developed reimbursement landscape. Key Attributes: Report Attribute Details No. of Pages 320 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $2.5 Billion Forecasted Market Value (USD) by 2030 $4.5 Billion Compound Annual Growth Rate 10.1% Regions Covered Global Companies Featured Exact Sciences Corporation GRAIL, LLC Veracyte, Inc. Natera, Inc. Guardant Health F. Hoffmann-La Roche Ltd FOUNDATION MEDICINE, INC. QIAGEN mdxhealth Bio-Techne For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Minimal Residual Disease Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
